(Q43923751)

28 November 2017

title

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia (English)

1 reference

28 November 2017

0 references

1 reference

cognitive dysfunction

1 reference

1 reference

4

Philip D Harvey

1 reference

28 November 2017

Joseph I Friedman

1

1 reference

28 November 2017

David N Adler

2

1 reference

28 November 2017

Evelyn Howanitz

3

1 reference

28 November 2017

Grant Brenner

5

1 reference

28 November 2017

Humberto Temporini

6

1 reference

28 November 2017

Leonard White

7

1 reference

28 November 2017

Michael Parrella

8

1 reference

28 November 2017

Kenneth L Davis

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

published in

Biological Psychiatry

1 reference

28 November 2017

volume

51

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

349-357

1 reference

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Schizophrenia, sensory gating, and nicotinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

The effects of physostigmine and scopolamine on recognition memory in monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Deficits in passive-avoidance learning following atropine in the developing rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Memory and cognitive function in man: Does the cholinergic system have a specific role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Physostigmine and lithium response in the schizophrenias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Cortical cholinergic markers in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Prevalence of smoking among psychiatric outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Physostigmine and cognition in schizotypal personality disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Nicotinic receptor function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Development of nicotinic drug therapy for cognitive disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Cholinergic gating of response to auditory stimuli in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Noncompetitive agonism at nicotinic acetylcholine receptors; functional significance for CNS signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed non-matching to sample and spatial learning in the water maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

[Investigation about an influence of physostigmine on schizophrenic symptoms (author's transl)]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Postmortem studies in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

Distributions of nicotinic acetylcholine receptor alpha7 and beta2 subunits on cultured hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901342-7

10.1016/S0006-3223(01)01342-7

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference